The Big Data Blog

Launch clarifies how science, healthcare, philanthropy, advisory services, and investment work together under one enterprise vision. [Boston, MA] — Melhem Holdings today announced the launch of a new enterprise brand and a coordinated identity system for Melhem Holdings and its portfolio entities: Melhem Scientific, Melhem Pharmaceuticals, Melhem Foundation, Melhem Consultancy, and Melhem Investments. The initiative is designed to make a complex ecosystem feel clear, intenti

New Shanghai-Based Enterprise to Accelerate Global Healthcare Innovation, Artificial Intelligence, Biotechnology, Digital Health, and Medical Technology Commercialization WASHINGTON, D.C. — Melhem Medical Technologies, Inc. (MMT), a United States-based healthcare innovation company, and Shanghai Xinhao International Trade Co., Ltd. (Xinhao), a leading China-based international trade and business development enterprise, today announced the signing of a strategic Joint Venture

Memorandum of Understanding aligns research, pharmaceutical execution, and global access initiatives Discovery to delivery—powered by science, strengthened by global access. WASHINGTON, D.C., April 30, 2026 — Melhem Scientific and Melhem Pharmaceuticals today announced the formal signing of a Memorandum of Understanding (MOU), establishing a unified strategic framework to accelerate collaboration across research, pharmaceutical access, and healthcare innovation. The agreeme

Melhem Scientific proudly announces the appointment of Dr. Mohamad Zakaria Koubeissi as Vice Chair of the Board of Scientific Advisors, marking a significant advancement in the organization’s commitment to global scientific leadership and medical innovation. Dr. Koubeissi is an internationally respected physician-scientist, academic leader, and expert in neurology, epilepsy, and disorders of consciousness. He currently serves as the Meta A. Neumann Professor and Chair of the

Operation Elevate marked a defining step forward for Melhem Holdings and its subsidiaries. The discussions reinforced a clear reality: we are no longer operating within limited boundaries. We are building a globally positioned institution with the scale, discipline, and ambition to expand across the Middle East and Africa while strengthening our strategic ties with Europe. The meeting brought strong alignment across leadership. We conducted a focused review of Q1 performanc

Melhem Scientific proudly announces the appointment of Dr. Bakhos Tannous as Chair of the Board of Advisors, marking a pivotal milestone in the organization’s global scientific mission. Dr. Tannous is an internationally renowned scientist, educator, and visionary leader in biomedical research, particularly in cancer and brain tumor therapeutics. With over 150 peer-reviewed publications and review articles, he has built a distinctive legacy in advancing multidisciplinary teams

FOR IMMEDIATE RELEASE Melhem Scientific President Nehme G. Melhem Officially Invited to Join the Forbes Business Council Washington DC, United States — November 4, 2025 — Melhem Scientific is proud to announce that its President, Nehme G. Melhem, has been officially invited and enlisted into the Forbes Business Council, a premier international community recognized for leadership excellence, business innovation, and meaningful global impact. The invitation reflects Mr. Melhem’

FOR IMMEDIATE RELEASE Washington, D.C., October 28, 2025 -- Melhem Scientific proudly announces the establishment of its newest division, the Department of Artificial Intelligence and Global Health Informatics , a pioneering step in integrating artificial intelligence and advanced informatics into global medical and research practices. The new department will serve as a hub for innovation, bridging medicine, data science, and technology to develop intelligent systems that imp